{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:47:05Z","timestamp":1788353225735,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"DOI":"10.1007\/s00467-026-07491-4","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:16:56Z","timestamp":1784801816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patterns of kidney involvement after corticosteroid treatment for extrarenal symptoms in pediatric IgA vasculitis (Henoch\u2013Sch\u00f6nlein Purpura): phenotypes and outcomes"],"prefix":"10.1007","author":[{"given":"Da Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Sung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Jun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5358-7966","authenticated-orcid":false,"given":"Jiwon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"7491_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2165\/00063030-200115020-00004","volume":"15","author":"G Rostoker","year":"2001","unstructured":"Rostoker G (2001) Schonlein-henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs 15:99\u2013138","journal-title":"BioDrugs"},{"key":"7491_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/BOR.0b013e32833af608","volume":"22","author":"FT Saulsbury","year":"2010","unstructured":"Saulsbury FT (2010) Henoch-Schonlein purpura. Curr Opin Rheumatol 22:598\u2013602","journal-title":"Curr Opin Rheumatol"},{"key":"7491_CR3","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S0140-6736(07)60474-7","volume":"369","author":"FT Saulsbury","year":"2007","unstructured":"Saulsbury FT (2007) Clinical update: Henoch-Schonlein purpura. Lancet 369:976\u2013978","journal-title":"Lancet"},{"key":"7491_CR4","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3390\/jcm13051290","volume":"13","author":"SH Park","year":"2024","unstructured":"Park SH, Jo SM, Kim SW, Lee JM, Baek HS (2024) An investigation of the relationship between Henoch-Schonlein purpura and viral infection in Korea using the health insurance database. J Clin Med 13:1290","journal-title":"J Clin Med"},{"key":"7491_CR5","first-page":"62","volume":"46","author":"N Grover","year":"2007","unstructured":"Grover N, Sankhyan N, Bisht JP (2007) A five year review of clinical profile in HSP. JNMA J Nepal Med Assoc 46:62\u201365","journal-title":"JNMA J Nepal Med Assoc"},{"key":"7491_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/00005792-199911000-00005","volume":"78","author":"FT Saulsbury","year":"1999","unstructured":"Saulsbury FT (1999) Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 78:395\u2013409","journal-title":"Medicine (Baltimore)"},{"key":"7491_CR7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1136\/archdischild-2013-303642","volume":"98","author":"J Dudley","year":"2013","unstructured":"Dudley J, Smith G, Llewelyn-Edwards A, Bayliss K, Pike K, Tizard J (2013) Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein purpura (HSP). Arch Dis Child 98:756\u2013763","journal-title":"Arch Dis Child"},{"key":"7491_CR8","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1136\/adc.2005.074641","volume":"90","author":"H Narchi","year":"2005","unstructured":"Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90:916\u2013920","journal-title":"Arch Dis Child"},{"key":"7491_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jpeds.2006.03.024","volume":"149","author":"J Ronkainen","year":"2006","unstructured":"Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J et al (2006) Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 149:241\u2013247","journal-title":"J Pediatr"},{"key":"7491_CR10","first-page":"Cd005128","volume":"2015","author":"D Hahn","year":"2015","unstructured":"Hahn D, Hodson EM, Willis NS, Craig JC (2015) Interventions for preventing and treating kidney disease in Henoch-Sch\u00f6nlein Purpura (HSP). Cochrane Database Syst Rev 2015:Cd005128","journal-title":"Cochrane Database Syst Rev"},{"key":"7491_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1741-7015-2-7","volume":"2","author":"AM Huber","year":"2004","unstructured":"Huber AM, King J, McLaine P, Klassen T, Pothos M (2004) A randomized, placebo-controlled trial of prednisone in early Henoch Sch\u00f6nlein Purpura [ISRCTN85109383]. BMC Med 2:7","journal-title":"BMC Med"},{"key":"7491_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF00861574","volume":"7","author":"FT Saulsbury","year":"1993","unstructured":"Saulsbury FT (1993) Corticosteroid therapy does not prevent nephritis in Henoch-Sch\u00f6nlein purpura. Pediatr Nephrol 7:69\u201371","journal-title":"Pediatr Nephrol"},{"key":"7491_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/joneph\/20.4.406","volume":"20","author":"US Bayrakci","year":"2007","unstructured":"Bayrakci US, Topaloglu R, Soylemezoglu O, Kalyoncu M, Ozen S, Besbas N et al (2007) Effect of early corticosteroid therapy on development of Henoch-Sch\u00f6nlein nephritis. J Nephrol 20:406\u2013409","journal-title":"J Nephrol"},{"key":"7491_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/adc.2008.141820","volume":"94","author":"W Chartapisak","year":"2009","unstructured":"Chartapisak W, Opastiraku S, Willis NS, Craig JC, Hodson EM (2009) Prevention and treatment of renal disease in Henoch-Sch\u00f6nlein purpura: a systematic review. Arch Dis Child 94:132\u2013137","journal-title":"Arch Dis Child"},{"key":"7491_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1\u2013S276","journal-title":"Kidney Int"},{"key":"7491_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1067\/mpd.2000.103448","volume":"136","author":"BJ Foster","year":"2000","unstructured":"Foster BJ, Bernard C, Drummond KN, Sharma AK (2000) Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136:370\u2013375","journal-title":"J Pediatr"},{"key":"7491_CR17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/ard.2009.116657","volume":"69","author":"S Ozen","year":"2010","unstructured":"Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R et al (2010) EULAR\/PRINTO\/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 69:798\u2013806","journal-title":"Ann Rheum Dis"},{"key":"7491_CR18","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/rheumatology\/kez041","volume":"58","author":"S Ozen","year":"2019","unstructured":"Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T et al (2019) European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 58:1607\u20131616","journal-title":"Rheumatology (Oxford)"},{"key":"7491_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00467-024-06502-6","volume":"40","author":"M Vivarelli","year":"2025","unstructured":"Vivarelli M, Samuel S, Coppo R, Barratt J, Bonilla-Felix M, Haffner D et al (2025) IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis. Pediatr Nephrol 40:533\u2013569","journal-title":"Pediatr Nephrol"},{"key":"7491_CR20","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s10067-017-3972-3","volume":"37","author":"IM Buscatti","year":"2018","unstructured":"Buscatti IM, Casella BB, Aikawa NE, Watanabe A, Farhat SCL, Campos LMA et al (2018) Henoch-Sch\u00f6nlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center. Clin Rheumatol 37:1319\u20131324","journal-title":"Clin Rheumatol"},{"key":"7491_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14093055","volume":"14","author":"Z Podraza","year":"2025","unstructured":"Podraza Z, Poplicha K, Ufniarski T, Ucieklak J, \u0141ysiak N, Mizerska-Wasiak M (2025) Laboratory findings and clinical features in IgA vasculitis: identifying predictors of kidney involvement and disease relapse in pediatric patients. J Clin Med 14:3055","journal-title":"J Clin Med"},{"key":"7491_CR22","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1136\/adc.2009.182394","volume":"95","author":"O Jauhola","year":"2010","unstructured":"Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, H\u00f6ltt\u00e4 T et al (2010) Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children. Arch Dis Child 95:877\u2013882","journal-title":"Arch Dis Child"},{"key":"7491_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrneph.2014.126","volume":"10","author":"JC Davin","year":"2014","unstructured":"Davin JC, Coppo R (2014) Henoch-Sch\u00f6nlein purpura nephritis in children. Nat Rev Nephrol 10:563\u2013573","journal-title":"Nat Rev Nephrol"},{"key":"7491_CR24","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1681\/ASN.2014070697","volume":"26","author":"V Tesar","year":"2015","unstructured":"Tesar V, Troyanov S, Bellur S, Verhave JC, Cook HT, Feehally J et al (2015) Corticosteroids in IgA nephropathy: a retrospective analysis from the VALIGA study. J Am Soc Nephrol 26:2248\u20132258","journal-title":"J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07491-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07491-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07491-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:36:08Z","timestamp":1788312968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-026-07491-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":24,"alternative-id":["7491"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07491-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9217404\/v1","asserted-by":"object"}]},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institutional Review Board (IRB No. 2026\u20130016), with a waiver of informed consent. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}